2020
DOI: 10.1186/s13287-019-1536-y
|View full text |Cite
|
Sign up to set email alerts
|

Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction

Abstract: Stem cell-derived sheet engineering has been developed as the next-generation treatment for myocardial infarction (MI) and offers attractive advantages in comparison with direct stem cell transplantation and scaffold tissue engineering. Furthermore, induced pluripotent stem cell-derived cell sheets have been indicated to possess higher potential for MI therapy than other stem cell-derived sheets because of their capacity to form vascularized networks for fabricating thickened human cardiac tissue and their lon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
59
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 87 publications
(59 citation statements)
references
References 101 publications
0
59
0
Order By: Relevance
“…BMMSCs exert their paracrine effects on organ damage repair and microenvironmental and immune regulation [32] and have been shown to promote organ and tissue repair [33][34][35]. However, BMMSC therapy is limited by low colonization rate and short survival time post transplantation.…”
Section: Discussionmentioning
confidence: 99%
“…BMMSCs exert their paracrine effects on organ damage repair and microenvironmental and immune regulation [32] and have been shown to promote organ and tissue repair [33][34][35]. However, BMMSC therapy is limited by low colonization rate and short survival time post transplantation.…”
Section: Discussionmentioning
confidence: 99%
“…Cell sheet transplantation is a well-established technique that allows sheet formation of adherent cultured cells via cell–cell junctions and physical detachment from the culture dish surface under temperature differential conditions [ [20] , [21] , [22] ]. By using a cell sheet, considerably numerous cells can be stably transplanted into the damaged myocardium, depending on the cell sheet size [ [23] , [24] , [25] ].…”
Section: Introductionmentioning
confidence: 99%
“…The Endothelial Progenitor Cells (EPC) treatment strategy take advantages of preserving or regenerating tissue to develop towards clinical application [1][2][3]. However, the disadvantage of single cells transplantation related aggregation and necrosis make the the feasibility and effectiveness of the approach remain insu cient and di cult in clinical trials [4,5].…”
Section: Introductionmentioning
confidence: 99%